logo
Africa Centres for Disease Control and Prevention (CDC) Supports Angola to Fight Cholera

Africa Centres for Disease Control and Prevention (CDC) Supports Angola to Fight Cholera

Zawya10-04-2025

Angola received 2,000 life-saving oral cholera vaccines for frontline healthcare workers from the Africa Centres for Disease Control and Prevention (Africa CDC) in March 2025.
Dr. Ngashi Ngongo, Principal Advisor to the Director General of Africa CDC on Programs, represented H.E. Dr. Jean Kaseya at the handover ceremony of oral cholera vaccines in Luanda, Angola.
The vaccines are part of Africa CDC's efforts to support Angola's response to multiple health emergencies, including cholera and Mpox. Since the cholera outbreak, Africa CDC has deployed 10 healthcare experts to support surveillance, preparedness and response, laboratory capacity, IPC, case management, and environmental surveillance. It has also procured WASH supplies and provided capacity-building training for healthcare workers.
Dr. Silvia Lutucuta, Angola's Minister of Health, praised Africa CDC's efforts in dedicating vaccines to frontline healthcare workers, who put their lives on the line daily to care for those affected by infectious diseases like cholera, Mpox, and Marburg. This move recognizes the vital role healthcare workers play in combating these health crises.
Africa CDC has developed a three-month Incident Action Plan to help tackle the cholera outbreak in Angola. On February 8, the government of Angola received support from a multidisciplinary team of experts from Africa CDC's Southern Africa Regional Coordinating Centre (SARCC).
After the first case was confirmed in the municipality of Cacuaco, Luanda Province, on January 7, 2025, the Angolan Ministry of Health declared a new cholera outbreak.
As of March 8, 2025, there have been 11,307 cases and 421 deaths since the outbreak began. This gives a case fatality rate of 3.6%. Of the deaths, 289 (69%) occurred in health facilities, and 132 (31%) in communities. These cases have been reported in 17 out of 21 provinces: Namibe, Luanda Sul, Bie, Benguela, Cubango, Uige, Cabinda, Cuanza Sul, Cunene, Luanda, Huambo, Huila, Icolo e Bengo, Bengo, Malanje, Zaire, and Cuanza Norte.
A total of 17 provinces have reported cholera cases to date, while Luanda, Bengo, Cuanza Norte, and Icolo e Bengo are the epicentres of the cholera outbreak, constituting approximately 98% of all cases.
A situational report from Africa CDC on February 28 shows that Bengo Province has the highest attack rate at 31.6 per 10,000 people. This highlights how rural provinces with poor water and sanitation can see average attack rates over 5%.
Among the country's response and control measures, Angola's President, H.E. João Lourenço, plays a significant role in the cholera outbreak response, including making regular supportive visits to affected communities.
The Angolan government has a funded national response plan for cholera worth USD 6.5 million, which covers multiple sectors. The country has activated technical working groups at national and provincial levels to coordinate the response. Key pillars include coordination and leadership, surveillance, laboratory, case management, water, sanitation and hygiene (WASH), infection prevention and control (IPC), vaccination, risk communication, and community engagement.
A national Cholera Interministerial Commission has been established, chaired by Minister of Health Dr. Lutucuta. The Commission holds weekly coordination meetings and conducts joint support visits to affected communities.
As part of the response, communities are now being provided with potable safe water. The government, through the Luanda Provincial Governor, has temporarily closed the Mabunda fish market due to poor water and sanitation services. Authorities are coordinating the provision of clean water and sanitation services to the market and have issued an official closure notice.
There are plans to enhance the community referral system. The government has established cholera treatment centres in all affected communities and created community oral rehydration points for case management.
The Ministry of Health received 948,500 doses of the Euvichol® vaccine on January 28, 2025, from the International Coordination Group on Vaccine Provision. The oral cholera vaccination campaign took place in Luanda, Icolo e Bengo, and Bengo provinces from February 3 to February 8, 2025. A total of 925,026 people were vaccinated, achieving 86% vaccination coverage.
The cholera outbreak in Angola is ongoing. Each day, there is an average of 120 new cases and five deaths. The report suggests that Africa CDC should continue to provide on-the-ground support for the cholera response, including regular visits to treatment centres for technical support and assistance in investigating the outbreak and identifying risk factors in affected communities.
The report emphasizes the need for enhanced on-the-job training for health workers at cholera treatment centres. This training should focus on surveillance, case management, and IPC. It also recommends strengthening risk communication and engaging communities through multiple platforms to encourage early health-seeking behaviour and improve referrals.
'Africa CDC greatly appreciates the strides the Government of Angola has made toward the ongoing cholera response,' said Batsirai Mbodza, Africa CDC's Southern Africa Region Mpox Incident Manager, currently based in Angola.
The Africa CDC team on the ground is supporting government efforts in collaboration with the multidisciplinary team and partners in Angola. The response spans national, provincial, and municipal levels. 'Given the response initiatives, Africa CDC recommends greater focus on and strengthened access to care, promptness of care, and quality of care to reduce the current high case fatality rate,' said Mbodza.
Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cairo hosts the 4th Edition of 'Africa Health ExCon' from June 25–27
Cairo hosts the 4th Edition of 'Africa Health ExCon' from June 25–27

Zawya

timea day ago

  • Zawya

Cairo hosts the 4th Edition of 'Africa Health ExCon' from June 25–27

Under the Patronage of H.E. President Abdel Fattah Al Sisi: Cairo, Egypt: The Egyptian Authority for Unified Procurement (UPA), Medical Supply and Technology Management announced the launch of the fourth edition of ' Africa Health ExCon ', the largest and most significant healthcare event across Africa. The event will be held under the patronage of His Excellency President Abdel Fattah El-Sisi from June 25 to 27, 2025, at Al Manara International Conference Center, Egypt's International Exhibition Center (EIEC). It is organized in collaboration with both the Africa Centers for Disease Control and Prevention (Africa CDC) and the African Union Development Agency (AUDA-NEPAD). This high-level cooperation reflects the growing international and continental stature of the event, further cementing Egypt's position as a leading regional hub for medical care in Africa. This year's edition of ' Africa Health ExCon 2025' is held under the theme: "Innovation and Independence: Leveraging Artificial Intelligence and Local Manufacturing to Strengthen African Health Systems", which highlights the continent's most pressing priorities. The event focuses on two main pillars: deepening local manufacturing of pharmaceuticals and medical supplies within the continent to achieve self-sufficiency, and integrating artificial intelligence (AI) technologies into the management and operation of healthcare systems. These pillars aim to establish health independence and reduce reliance on external imports, ultimately advancing Africa's health sovereignty and resilience. The fourth edition is expected to attract over 350 local, regional, and international companies, and 42,743 visitors from around the globe. Participants will engage in over 21 panel discussions, technical sessions, and workshops covering vital topics such as digital health, research and development, smart systems, and sustainable manufacturing. Commenting on Egypt's hosting of this event, Dr. Hisham Stait, Chairman of the Egyptian Authority for Unified Procurement, Medical Supply, and the Management of Medical Technology (UPA), stated: 'Over the past editions, 'Africa Health ExCon' has proven to be more than just an annual event, it has evolved into an integrated platform that brings together all key players within the African healthcare ecosystem. It is where policymakers convene to set regulatory frameworks, the industrial sector showcases its latest innovations, research institutions exchange knowledge, and private sector representatives explore partnership and investment opportunities. This unique gathering aims to shape a unified and comprehensive vision for the future of healthcare in Africa, in alignment with the Sustainable Development Goals (SDGs).' He added: 'This year, we are placing a special emphasis on opportunities for intra-African cooperation and integration, driven by our firm belief that achieving health sovereignty in Africa depends on solidarity and collective action. The continent possesses the capabilities and human capital needed to attain self-sufficiency across various medical fields, and that's what we aim to promote and activate through this vital forum.' For his part, Dr. Kamal Ebeid, Executive Director of Africa Health ExCon, stated: 'We take pride in this event as it serves as a real launchpad for strengthening Egypt's role as a bridge for African healthcare integration and a pivotal regional hub for medical manufacturing and innovation. We hope this year's edition outlines a clear roadmap for the future of healthcare across the continent. By supporting local manufacturing of pharmaceuticals and medical supplies, we aim to achieve Africa's health independence and reduce our reliance on global supply chains that have shown vulnerability during crises.' He added: 'There is a growing global focus on harnessing artificial intelligence to revolutionize the management and operation of healthcare systems. That's why the 2025 edition of Africa Health ExCon is set to be truly exceptional not just in the types of partnerships we're building, but also in the scale of high-level institutional participation and the depth of international engagement that will bring togeher leading minds from around the world to explore how AI can be practically and meaningfully applied to improve the health and lives of people across Africa.' For the first time, this year's exhibition will feature the launch of the AI Pavilion, a fully dedicated space showcasing the latest breakthroughs in medical artificial intelligence. This pavilion will host global companies and leading research centers, highlighting advanced AI applications in areas such as precision diagnostics, complex health data management, epidemic prediction, and smart hospital operations. This marks a significant step forward in connecting advanced technology with the realities of Africa's healthcare systems and opens new avenues for innovation and improvement in health services across the continent. Africa Health ExCon serves as a vital platform for healthcare and pharmaceutical companies to explore Africa's vast investment potential. The conference aims to strengthen intra-African trade as an essential pillar of the African Union's Agenda 2063, thereby accelerating growth in these strategic industries. This approach aligns with Egypt's Vision 2030, which emphasizes deepening local manufacturing, fostering African cooperation, and embracing the latest technological and digital tools in the healthcare sector. These efforts contribute to achieving sustainable health security, pharmaceutical sovereignty, and universal health coverage across Africa. This year's edition is supported by a wide range of leading global healthcare companies, with 22 official sponsors contributing to the event's success, further solidifying it's position as a global destination for experts and investors. The Platinum sponsors include Genvax Technologies, Roche, GE Healthcare, Clinilab; the Gold sponsors include, Janssen Pharmaceuticals, Opella, and Sanofi; while the Silver sponsor is Bayer. The third edition of Africa Health ExCon 2024, held under the theme of " Your Gateway to Innovation and Trade" witnessed a remarkable success. It attracted approximately 48 healthcare and trade professionals from 142 countries, with over 360 government healthcare representatives, CEOs, and decision-makers attending from across the globe. The event featured 32 scientific conferences, 32 workshops, and 264 sessions, with the participation of 1410 speakers. A total of 350 exhibitors showcased their state-of-the-art products and innovation in medical technology, while 25 sponsors, 5 pavilions, and 24 international partners participated in the event. The conference addressed strategies for developing a sustainable healthcare system in Africa, demonstrating a strong commitment to improving healthcare services across the continent. It also provided an ideal platform for healthcare and pharmaceutical companies to explore investment opportunities in Africa, thereby accelerating growth of these industries continent-wide. Furthermore, the event played a vital role in fostering public-private partnerships in the medical field, unlocking new avenues for investment and trade. About the UPA: It is a national economic entity under the presidency of the Egyptian Cabinet. It aims to ensure equitable access to medical and healthcare technology products through scientifically based technological assessments, efficient strategic procurement processes, and supply chain management. The authority strives to be a strategic partner enabling effective resource utilization and sustainable, equitable access to medical technology at the national level.

PureHealth drives insurance business growth with Daman's entry into Property and Casualty insurance market
PureHealth drives insurance business growth with Daman's entry into Property and Casualty insurance market

Web Release

time3 days ago

  • Web Release

PureHealth drives insurance business growth with Daman's entry into Property and Casualty insurance market

PureHealth, the largest hospital and health insurance group in the Middle East, today announced the strategic expansion of its insurance arm, Daman, marking its transformation from a health-focused provider into a comprehensive, multi-line insurer with entry into the high-growth Property and Casualty (P&C) segment. As part of this evolution, Daman will adopt a new legal name: The National Insurance Company – Daman, reflecting its broadened scope and strengthened position within the UAE's dynamic insurance landscape. The transition reflects Daman's broader mission to meet the evolving protection needs of individuals and businesses across the emirates by offering them a broader suite of insurance services. As the insurance arm of PureHealth and the UAE's leading health insurer, Daman's expansion into the P&C segment supports its vision to become a comprehensive insurance provider and aligns with the group's commitment to deliver holistic care and coverage throughout all stages of life. Shaista Asif, Group Chief Executive Officer of PureHealth, stated: 'Daman's evolution reflects PureHealth's broader strategy to create a fully integrated healthcare and insurance platform that drives better customer service and long-term value creation. Expanding into the Property and Casualty segment enhances portfolio diversification, supports risk management across sectors, and reinforces our commitment to shaping a future-ready ecosystem aligned with the UAE's economic and social development priorities.' H.E. Khaled Binshaiban Almheiri, Chairman of The National Insurance Company – Daman, commented: 'For nearly two decades, Daman has set the benchmark for health insurance in the UAE. This evolution marks a pivotal chapter – expanding our focus to offer a broader range of insurance solutions while maintaining the same rigour, trust and customer-first mindset our members know and value. By protecting individuals, businesses and assets, we are proud to play a central role in supporting the UAE's vision for sustainable wellbeing and long-term economic resilience.' Daman currently provides health coverage to more than three million members across a network of over 3,000 healthcare providers in the UAE. Backed by a resilient operational backbone, Daman brings together AI-powered underwriting, industry-leading efficiency in claim settlement, and a multilingual service delivery infrastructure to seamlessly support its expansion into new insurance verticals, without compromising its longstanding reputation for excellence. As per the Central Bank of the UAE (CBUAE), the total number of written insurance policies for all types of insurance within the UAE increased to 14.6 million policies year-on-year in 2023, compared to 8.4 million policies in 2022, due to a higher number of property and liability insurance policies. The UAE's P&C insurance market is poised for further accelerated growth, which is projected to reach nearly USD 16.8 billion by 2031, according to Verified Market Research. In response to this growing demand, the company will continue to operate under the well-established Daman brand, introducing new P&C products in phases while ensuring uninterrupted service for existing members. Daman was named the best perceived health insurance brand in the UAE, according to the UAE Healthcare 2024 report from Brand Finance – a recognition that reflects its commitment to excellence and mission to cultivate a healthier community. This strategic growth plan reinforces PureHealth's broader vision to advance the science of longevity and deliver the promise of holistic care, from prevention to protection, through a connected health and insurance ecosystem.

World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC) and Robert Koch Institute (RKI) expand unique partnership to strengthen collaborative surveillance in Africa
World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC) and Robert Koch Institute (RKI) expand unique partnership to strengthen collaborative surveillance in Africa

Zawya

time7 days ago

  • Zawya

World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC) and Robert Koch Institute (RKI) expand unique partnership to strengthen collaborative surveillance in Africa

The World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC) and the Robert Koch Institute (RKI) announced today the expansion of the successful Health Security Partnership to Strengthen Disease Surveillance in Africa (HSPA) to seven countries on the continent. The Health Security Partnership strengthens disease surveillance and epidemic intelligence across the African Continent, enabling countries to better detect and respond to public health threats – whether they are natural, accidental, or deliberate. Launched in 2023 in six countries, The Gambia, Mali, Morocco, Namibia, South Africa, and Tunisia, the partnership will expand to other countries, including Rwanda, in its second phase which runs from 2025-2028. 'HSPA represents an important step forward in building stronger partnerships for health security in Africa. By bringing together global, regional and national actors, this initiative supports countries in strengthening Collaborative Surveillance through mutual exchange and practical action. WHO remains committed to working alongside Member States to ensure that these collective efforts are well-coordinated, responsive, and rooted in national priorities,' said Dr Chikwe Ihekweazu, Acting WHO Regional Director for Africa; Deputy Executive Director, WHO Health Emergencies Programme. Africa experiences more disease outbreaks than any other part of the world. While significant progress has been made in strengthening disease surveillance over the past decade, no country can tackle today's complex health threats alone. 'Within the framework of this project, Africa CDC will work with the Member States in mobilizing political will for biosecurity and surveillance, establishing regional frameworks for bio-surveillance of high-consequence biological agents and toxins, and coordinating event-based surveillance. The collaboration with other partners and coordination with Member States is crucial especially in the current context of limited resources to strengthen the continent's capacity for early detection, response, and management of biological threats,'said Dr Raji Tajudeen, Acting Deputy Director General and Head, Division of Public Health Institutes and Research, Africa CDC. At the heart of the initiative is a Collaborative Surveillance approach that connects health and security sectors to reduce biological risks and strengthen surveillance systems nationally and internationally. The partnership is supporting countries to strengthen capacities in biorisk management, event and indicator-based surveillance, genomic surveillance and epidemic intelligence. This is achieved through training, guidance development, co-creation of implementation roadmaps, and hands-on technical assistance to ensure that implementation is aligned with country priorities, embedded within broader national systems, and built for long-term sustainability. 'We are proud of what this partnership has achieved so far. It has strengthened health system coordination and resilience in the African Continent, delivering tangible gains in biosecurity, disease surveillance, genomic surveillance, and epidemic intelligence. This has only been possible because of the trusted partnership between Africa CDC, RKI and WHO with countries in the driver's seat,' said Dr Merawi Aragaw, Head of Surveillance and Disease at Africa CDC. The HSPA initiative has been supported from the start by the Government of Canada through its Weapons Threat Reduction Program, with additional funding in phase two from the Government of the United Kingdom. Building on the achievements in phase one, the participating countries, with support from WHO and partners, will accelerate implementation to build a healthier, safer and more resilient Africa. Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store